Published May 22, 2023

Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health | Huberman Lab Podcast

Dr. Robin Carhart-Harris delves into the pioneering science of psychedelics like psilocybin and MDMA for mental health, discussing their impact on brain plasticity, potential therapeutic advantages, and the evolving legal landscape of clinical trials.
Episode Highlights
Huberman Lab logo

Popular Clips

Questions from this episode

Episode Highlights

  • Psilocybin & Depression

    explores the transformative potential of psilocybin in treating depression. He highlights how psilocybin therapy has shown remarkable results, often outperforming traditional treatments like SSRIs. In clinical trials, psilocybin doses ranging from 10 to 25 milligrams have been linked to significant improvements in mood and cognitive flexibility, suggesting a profound impact on brain neuroplasticity 1 2.

    It's more than impulse that is leading us to think that the experience is important. It's really data and converging evidence.

    ---

    The therapy's effectiveness is not merely a placebo response, as evidenced by the lack of correlation between pretrial expectancy and therapeutic outcomes in psilocybin trials 2.

       

    MDMA Therapy

    MDMA therapy emerges as a promising treatment for PTSD, with noting its ability to facilitate therapeutic progress by making it easier for patients to confront trauma. Unlike psilocybin, MDMA provides a gentler approach, allowing patients to revisit traumatic memories without overwhelming fear or dissociation 3.

    It's a strength because while the classics like psilocybin can take you there very reliably, but maybe a bit aggressively, MDMA makes it easier to go there.

    ---

    The FDA is currently reviewing phase three trials, which have shown impressive remission rates for trauma, potentially leading to the legal prescription of MDMA for therapeutic use 4 5.

       

    Therapy Techniques

    Psychedelic therapy incorporates various techniques to enhance its effectiveness, such as trust-building, music, and integration practices. emphasizes the mantra "trust, let go, be open," which guides patients through the psychedelic experience by fostering a sense of safety and openness 6.

    Trust, let go, be open.

    ---

    Integration is crucial, as it helps patients consolidate their experiences and insights post-session, potentially leading to long-lasting therapeutic benefits 7. Music also plays a key role, aiding in the emotional journey and helping patients navigate the complex phases of their psychedelic trips 8.

Related Episodes